Baker Biotech Capital Iii (gp), Llc - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Ocera Therapeutics Inc (OCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocera Therapeutics Inc (OCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ocera Therapeutics Inc (OCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Biotech Capital Iii (gp), Llc made no insider transaction in XOMA Royalty Corp (XOMA). Other recent insider transactions involving XOMA Royalty Corp (XOMA) include a net purchase of 9,100 shares made by Bradley Sitko , and a net purchase of 5,500 shares made by Owen Hughes .

In summary, during the past 3 months, insiders sold 0 shares of XOMA Royalty Corp (XOMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XOMA Royalty Corp (XOMA) were sold and 14,600 shares were bought by its insiders, resulting in a net purchase of 14,600 shares.

XOMA Royalty Corp (XOMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Biotech Capital Iii (gp), Llc made no insider transaction in Incyte Corp (INCY). Other recent insider transactions involving Incyte Corp (INCY) include a net sale of 40,484 shares made by Steven H Stein , a net sale of 28,618 shares made by Barry P Flannelly , and a net sale of 3,324 shares made by Thomas Tray .

In summary, during the past 3 months, insiders sold 46,037 shares of Incyte Corp (INCY) in total and bought 0 shares, with a net sale of 46,037 shares. During the past 18 months, 105,553 shares of Incyte Corp (INCY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 105,553 shares.

Incyte Corp (INCY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Biotech Capital Iii (gp), Llc made no insider transaction in Seagen Inc (SGEN). Other recent insider transactions involving Seagen Inc (SGEN) include a net sale of 36,274 shares made by Vaughn B Himes , a net sale of 2,228 shares made by Charles R Romp , and a net sale of 58,274 shares made by Todd E Simpson .

In summary, during the past 3 months, insiders sold 0 shares of Seagen Inc (SGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 195,202 shares of Seagen Inc (SGEN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 195,202 shares.

Seagen Inc (SGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Biotech Capital Iii (gp), Llc made no insider transaction in Heron Therapeutics Inc (HRTX). Other recent insider transactions involving Heron Therapeutics Inc (HRTX) include a net purchase of 2,486,744 shares made by Adam Morgan , and a net purchase of 50,000 shares made by William P Forbes .

In summary, during the past 3 months, insiders sold 0 shares of Heron Therapeutics Inc (HRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Heron Therapeutics Inc (HRTX) were sold and 2,536,744 shares were bought by its insiders, resulting in a net purchase of 2,536,744 shares.

Heron Therapeutics Inc (HRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Biotech Capital Iii (gp), Llc made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net purchase of 23,000 shares made by Helen M. Thackray , a net sale of 8,689 shares made by Machelle Sanders , and a net sale of 7,866 shares made by Nancy J Hutson .

In summary, during the past 3 months, insiders sold 8,600 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 8,600 shares. During the past 18 months, 43,853 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 139,748 shares.

BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Baker Biotech Capital Iii (gp), Llc made no insider transaction in Aceragen Inc (ACGN). Other recent insider transactions involving Aceragen Inc (ACGN) include a net sale of 264,324 shares made by Atul Chopra , a net purchase of 21,147 shares made by Pillar Invest Corp , and a net sale of 3,283 shares made by Vincent Milano .

In summary, during the past 3 months, insiders sold 0 shares of Aceragen Inc (ACGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 273,476 shares of Aceragen Inc (ACGN) were sold and 26,965 shares were bought by its insiders, resulting in a net sale of 246,511 shares.

Aceragen Inc (ACGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of XOMA Royalty Corp (XOMAO.PFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XOMA Royalty Corp (XOMAO.PFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

XOMA Royalty Corp (XOMAO.PFD)'s detailed insider trading history can be found in Insider Trading Tracker table.